Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Muhlert

Vascular & Interventional Radiology Memphis, TN Medical Doctor

NPI 1063630093 CMS profile 184787

5959 Park Ave, Mprg, Memphis, TN 38119

Open in the dashboard

General payments

$23,530

301 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Michael Muhlert of Memphis, TN is reported in the CMS Open Payments database as having received $23,530 across 301 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,644 41
2024 General $1,891 31
2023 General $2,420 38
2022 General $2,350 44
2021 General $10,328 48
2020 General $2,298 33
2019 General $2,599 66

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Muhlert
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Michael Muhlert were reported at $1,644. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Michael Muhlert Vascular & Interventional Radiology median Middle half National median
2019 $2,599 $422 $125–$1,555 $163
2020 $2,298 $200 $68–$652 $114
2021 $10,328 $280 $99–$866 $132
2022 $2,350 $433 $137–$1,497 $149
2023 $2,420 $506 $152–$2,019 $160
2024 $1,891 $556 $175–$1,930 $164
2025 $1,644 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Penumbra, Inc. $14,394 67 payments
  2. W. L. Gore & Associates, Inc. $1,817 61 payments
  3. Boston Scientific Corporation $1,362 38 payments
  4. Medtronic, Inc. $1,129 25 payments
  5. Inari Medical, Inc. $953 9 payments
  6. Imperative Care, INc $600 11 payments
  7. Shockwave Medical, Inc $345 12 payments
  8. Qapel Medical Inc $297 3 payments
  9. Cook Medical LLC $292 17 payments
  10. Stryker Corporation $281 4 payments
  11. Other $2,060 54 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $17,062 296 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,800 2 payments
  3. Travel and Lodging $1,668 3 payments
Products named General payments · program years 2019–2025
  1. Indigo System $10,763 38 payments
  2. Indigo $1,682 14 payments
  3. Penumbra System $1,195 9 payments
  4. FLOWTRIEVER CATHETER, S $1,155 10 payments
  5. GORE VIABAHN VBX Balloon Expandable Endo $569 15 payments
  6. GORE VIABAHN Endoprosthesis with Heparin $472 15 payments
  7. Ruby $433 4 payments
  8. ClotTriever $376 4 payments
  9. FlowTriever $376 4 payments
  10. ELUVIA $347 10 payments
  11. Other $6,909 181 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

48

Median for Interventional Radiology: 38

Drug cost

$317

Median for Interventional Radiology: $333

Branded share of claims

68.8%

Median for Interventional Radiology: 53%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clopidogrel Clopidogrel Bisulfate Brand 33 $256
Ciprofloxacin Hcl Generic 15 $61

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 554 Part D prescribers listed as Interventional Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 308 billing codes

Paid by Medicare

$182,131

Medicare's payments for the services billed

Medicare patients

2,519

Average age 74

Services billed

4,878

1,493 women, 1,026 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 57%
Diabetes 43%
Ischemic heart disease 43%
Chronic kidney disease 36%
Heart failure 33%
Depression 31%
COPD 30%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

301 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record